Clínica Dermatológica Internacional welcomes Dr Ignacio Gimeno to its medical team, reinforcing its commitment to Mohs micrographic surgery, the most precise technique for treating skin cancer.

Clínica Dermatológica Internacional (CDI), at its Ruber Internacional Centro Médico Masó and Ruber Internacional Centro Médico Habana locations, welcomes Dr Ignacio Gimeno Mateos, a specialist in medical-surgical dermatology and venereology, renowned for his extensive experience in the diagnosis, treatment and prevention of skin cancer and in advanced surgical procedures such as Mohs micrographic surgery, considered the most effective and precise technique in the treatment of skin tumours.
‘Mohs micrographic surgery allows skin cancer to be removed with maximum precision, ensuring complete removal of the tumour while preserving as much healthy tissue as possible,’ explains Dr Ignacio Gimeno. ‘This translates into higher cure rates and better aesthetic results, especially in such visible and delicate areas as the face or around the eyes.’
Unlike conventional surgery, the Mohs technique analyses all the lateral and deep margins of the excised tissue, thanks to a procedure that combines surgery and immediate microscopic examination in the laboratory.
The tissue is frozen and cut in a cryostat using specific cuts that allow the entire tumour to be visualised. If any tumour remains, the surgeon can know exactly where to continue the removal, eliminating only the affected area and preserving healthy tissue.
‘The main advantage is that we can confirm during the same surgical procedure that the tumour has been completely removed,’ says Dr Gimeno. ‘This certainty allows us to perform immediate reconstructions with optimal functional and aesthetic results.’
Mohs surgery is mainly recommended for tumours located in high-risk areas, such as the nose, eyelids or lips, where the preservation of healthy tissue is crucial. It is also used for aggressive tumours or those with poorly defined clinical margins.
According to the dermatological surgeon, who was head of the surgery department at the Skin Cancer Centre at Karolinska University Hospital (Sweden), one of the world's leading centres for dermatology, basal cell carcinoma—the most common skin tumour—is the main indication for this technique. It is also used in squamous cell carcinomas, selected melanomas and other less common tumours, such as dermatofibrosarcoma protuberans or extramammary Paget's disease. ‘We usually perform the procedure under local anaesthesia and mild sedation, which ensures greater comfort for the patient during the operation,’ concludes the doctor.